Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0089
-0.0003 (-3.26%)
Aug 1, 2025, 1:50 PM EDT
Altair Engineering Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
9.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | - | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
American Oncology Network | 1.76B |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
Curative Biotechnology News
- 8 months ago - Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor - GlobeNewsWire
- 1 year ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors - GlobeNewsWire
- 1 year ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors - GlobeNewsWire
- 2 years ago - Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions - GlobeNewsWire
- 2 years ago - Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation - GlobeNewsWire
- 2 years ago - Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study - GlobeNewsWire
- 3 years ago - Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange - GlobeNewsWire
- 3 years ago - Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors - GlobeNewsWire